Regulus Therapeutics
RGLS
#7320
Rank
ยฃ0.42 B
Marketcap
ยฃ6.10
Share price
0.00%
Change (1 day)
428.03%
Change (1 year)

Market capitalization of Regulus Therapeutics (RGLS)

Last known market cap: ยฃ0.42 Billion

On August 27, 2025 Regulus Therapeutics had a market cap of ยฃ0.42 Billion. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Regulus Therapeutics from 2012 to 2025

End of year Market Cap

Year Marketcap Change
2025ยฃ0.41 B421.89%
2024ยฃ80.38 M295.61%
2023ยฃ20.31 M6.54%
2022ยฃ19.07 M-44.02%
2021ยฃ34.06 M-45.84%
2020ยฃ62.89 M340.89%
2019ยฃ14.26 M120.67%
2018ยฃ6.46 M-91.92%
2017ยฃ79.99 M-17.11%
2016ยฃ96.5 M-68.86%
2015ยฃ0.30 B-38.54%
2014ยฃ0.50 B169.35%
2013ยฃ0.18 B34.04%
2012ยฃ0.13 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Sanofi
SNY
ยฃ79.41 B 18,706.04%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
ยฃ28.02 B 6,536.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ95.46 B 22,506.33%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
ยฃ216.37 B 51,139.30%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
ยฃ74.14 B 17,458.01%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sangamo Therapeutics
SGMO
ยฃ22.91 M-94.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
ยฃ2.22 B 427.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
ยฃ16.51 B 3,811.80%๐Ÿ‡บ๐Ÿ‡ธ USA